3SBio Inc. Announces Results of Annual General Meeting
SHENYANG, China, Sept. 15 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the results of the shareholder votes at its 2008 Annual Ge...
3SBio Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference
SHENYANG, China, Aug. 26 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announces that David Chen, Chief Operating Officer will present at the Morgan ...
3SBio Inc. to Hold Annual General Meeting
SHENYANG, China, Aug. 21 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the 2008 Annual General Meeting of Shareholders of 3SBio Inc. wi...
3SBio Inc. Announces Second Quarter 2008 Results
SHENYANG, China, Aug. 13 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the second quarter ended June 30,...
3SBio Inc. Schedules 2008 Second Quarter Earnings Release On Tuesday, August 12, 2008
Earnings Conference Call to be Held on August 13, 2008 at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) SHENYANG, China, July 30 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturi...
3SBio Inc. Announces Filing of Annual Report on Form 20-F
SHENYANG, China, July 1 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has filed with the SEC an annual report on ...
3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
SHENYANG, China, May 28 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announces that David Chen, Chief Operating Officer, and Kevin Teo...
AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
SHENYANG, China, May 28 /Xinhua-PRNewswire-FirstCall/ -- AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG) and 3SBio, Inc. (Nasdaq: SSRX), a leading Chinese biotechnology company, today announced the signing of a development and commercialization agreement for ferumoxytol, an intravenous iron replac...
3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
SHENYANG, China, May 19 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, will present at the Oppenheimer 2nd Annual China Dragon Call Conference in New ...
3SBio Inc. Announces First Quarter 2008 Results
-- Q1 2008 net revenues grew 56.8%, as compared to Q1 2007, to RMB55.5 million (US$7.9 million) -- Q1 2008 operating income grew 22.4%, as compared to Q1 2007, to RMB14.2 million (US$2.0 million) -- Q1 2008 net income grew 22.3%, as compared to Q1 2007, to RMB 19....
3SBio Inc. Schedules 2008 First Quarter Earnings Release on Wednesday, May 14, 2008
Earnings Conference Call to be held on May 15, 2008 at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing/Hong Kong) SHENYANG, China, April 29 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, ...
3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
SHENYANG, China, March 20 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) (“3SBio” or the “Company”), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the appointment of Dr. David ...
3SBio Inc. Approves Share Repurchase Program
SHENYANG, China, March 20 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) (“3SBio” or the “Company”), a leading, fully integrated, biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announced today tha...
3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
- Q4 2007 net revenues grew 29.8%, as compared to Q4 2006, to RMB45.7 million (US$6.3 million) - Q4 2007 net income grew 152.2%, as compared to Q4 2006, to RMB17.9 million (US$2.5 million) - 2007 fiscal year net revenues increased 41.0% year-over-year to RMB...
3SBio Inc. Announces Change to the Board of Directors
SHENYANG, China, Feb. 20 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that Mr. Mingde Yu has been appointed as a...
3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
Earnings Conference Call to be held on Thursday, February 21, 2008 at 5:00 am (Pacific) / 8:00 am (Eastern) / 9:00 pm (Beijing/Hong Kong) SHENYANG, China, Feb. 12 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researchin...
3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
SHENYANG, China, Jan. 30 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announces today that David Chen, VP of Business Development, will present at the Merr...
3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
SHENYANG, China, Jan. 29 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or the "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the appointment of Kevin Teo to the positi...
3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference
SHENYANG, China, Nov. 20 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announces today that David Chen, VP of Business Development, will present a...
3SBio Inc. Announces Third Quarter 2007 Results
SHENYANG, China, Nov. 13 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its financial results for the third quarter ended September...
